In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Metoclopramida Drug Master File in Korea (Metoclopramida KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Metoclopramida. The MFDS reviews the Metoclopramida KDMF as part of the drug registration process and uses the information provided in the Metoclopramida KDMF to evaluate the safety and efficacy of the drug.
After submitting a Metoclopramida KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Metoclopramida API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Metoclopramida suppliers with KDMF on PharmaCompass.